# Effects of Hemoadsorption on Vascular Integrity in Septic Shock

> **NCT07711197** · NA · NOT_YET_RECRUITING · sponsor: **Semmelweis University** · enrollment: 110 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DEVICE:** CytoSorb hemoadsorption
- **OTHER:** Standard Medical Therapy (SMT)

## Key facts

- **NCT ID:** NCT07711197
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711197, "Effects of Hemoadsorption on Vascular Integrity in Septic Shock". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*